Advertisement
Screener

Duquesne Family Office LLC Historic Quarter Change: Foreign ADRs, Sold Out

Duquesne Family Office LLC historic quarter change: Foreign ADRs, Sold out

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 23 quarters from 2013-06-30 to 2026-06-30, Duquesne Family Office LLC opened 4 positions, added to 0, reduced 1 and sold out of 4.

  • Q2 2025: Stock Ascendis Pharma A/S; Country of operation —; Class SPONSORED ADR; Shares before 158,720.
  • Q3 2014: Stock Astrazeneca PLC; Country of operation —; Class SPON ADR; Shares before 208,900.
  • Q2 2014: Stock Astrazeneca PLC; Country of operation —; Class SPONSORED ADR; Shares before 360,500.
  • Q1 2014: Stock Astrazeneca PLC; Country of operation —; Class SPONS ADR; Shares before 360,500.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1536411), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-15); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-13); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-12); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-14); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2011-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2025Ascendis Pharma A/S
CUSIP 04351P101
SPONSORED ADR158,7200-158,720$24,738$0-$24,7382025-08-15
Q3 2014Astrazeneca PLC
CUSIP 046353108
SPON ADR208,9000-208,900$15,523,000$0-$15,523,0002014-11-14
Q2 2014Astrazeneca PLC
CUSIP 046353108
SPONSORED ADR360,5000-360,500$23,389,000$0-$23,389,0002014-08-14
Q1 2014Astrazeneca PLC
CUSIP 046353108
SPONS ADR360,5000-360,500$21,403,000$0-$21,403,0002014-05-14

Similar Firms

Firm NameCountry13F ValueHoldings
Bollard Group LLCUnited States$0.003B305
Eurizon Asset Management Slovakia, sprav. spol., a.s.$0.003B5
RPM Capital Partners, LLCUnited States$0.003B1
WEDBUSH SECURITIES INCUnited States$0.003B1,237
Analyst IMS Investment Management Services Ltd.Israel$0.003B214
HERITAGE INVESTORS MANAGEMENT CORPUnited States$0.003B249
CX InstitutionalUnited States$0.003B1,548
NEW MEXICO EDUCATIONAL RETIREMENT BOARDUnited States$0.003B908
Kentucky Retirement SystemsUnited States$0.004B506
Compound Global Advisors, LLCUnited States$0.003B31